We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Combined Laser and Nanotube Therapy Destroys Kidney Tumors

By LabMedica International staff writers
Posted on 14 Aug 2009
A novel cancer treatment has been described that is based on carbon nanotubes that heat up when exposed to laser light and then destroy tumors into which they have been injected.

Investigators from Wake Forest University (Winston Salem, NC, USA) evaluated several protocols that involved injection of multiwalled carbon nanotubes (MWCNTs) directly into kidney tumors in a population of laboratory mice. More...
After injection of the nanotubes, the area of the tumors was subjected to various levels of laser light for different periods.

Data published in the July 20, 2009, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) revealed that injection of 100 micrograms of MWCNT followed by illumination for 30 seconds with a low power (three-watt) laser resulted in complete ablation of tumors and a more than nine month period of lasting remission in 80% of the mice. In contrast, mice that received no treatment, mice that received nanotubes with no laser treatment, and mice that received laser treatment without nanotubes died about 30 days into the study. The treatment caused minimal local toxicity with no evidence of systemic toxicity.

"You can actually watch the tumors shrinking until, one day, they are gone,” said senior author Dr. Suzy Torti, professor of biochemistry at Wake Forest University. "Not only did the mice survive, but they maintained their weight, did not have any noticeable behavioral abnormalities and experienced no obvious problems with internal tissues. As far as we can tell, other than a transient burn on the skin that did not seem to affect the animals and eventually went away, there were no real downsides--that is very encouraging. When dealing with cancer, survival is the endpoint that you are searching for. It is great if you can get the tumor to shrink, but the gold standard is to make the tumor shrink or disappear and not come back. It appears that we have found a way to do that.”

Related Links:
Wake Forest University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.